{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:42:46Z","timestamp":1760013766190,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s40123-019-00205-0","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T09:02:55Z","timestamp":1564650175000},"page":"511-517","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pharmacokinetics of Azithromycin, Levofloxacin, and Ofloxacin in Rabbit Extraocular Tissues After Ophthalmic Administration"],"prefix":"10.1007","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0147-027X","authenticated-orcid":false,"given":"Tatsuya","family":"Sakai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Shinno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,1]]},"reference":[{"issue":"1","key":"205_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1600-0420.2007.01006.x","volume":"86","author":"G H\u00f8vding","year":"2008","unstructured":"H\u00f8vding G. Acute bacterial conjunctivitis. Acta Ophthalmol. 2008;86(1):5\u201317.","journal-title":"Acta Ophthalmol"},{"issue":"16","key":"205_CR2","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1001\/jama.2013.280318","volume":"310","author":"AA Azari","year":"2013","unstructured":"Azari AA, Barney NP. Conjunctivitis. JAMA. 2013;310(16):1721\u20139.","journal-title":"JAMA."},{"issue":"10","key":"205_CR3","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0161-6420(82)34669-2","volume":"89","author":"JP McCulley","year":"1982","unstructured":"McCulley JP, Dougherty JM, Deneau DG. Classification of chronic blepharitis. Ophthalmology. 1982;89(10):1173\u201380.","journal-title":"Ophthalmology"},{"key":"205_CR4","first-page":"CD005556","volume":"5","author":"K Lindsley","year":"2012","unstructured":"Lindsley K, Matsumura S, Hatef E, Akpek EK. Interventions for chronic blepharitis. Cochrane Database Syst Rev. 2012;5:CD005556.","journal-title":"Cochrane Database Syst Rev."},{"issue":"1","key":"205_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ophtha.2018.10.018","volume":"126","author":"A Lin","year":"2019","unstructured":"Lin A, Rhee MK, Akpek EK, et al. Bacterial Keratitis Preferred Practice Pattern\u00ae. Ophthalmology. 2019;126(1):1\u201355.","journal-title":"Ophthalmology"},{"issue":"1","key":"205_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ophtha.2018.10.019","volume":"126","author":"G Amescua","year":"2019","unstructured":"Amescua G, Akpek EK, Farid M, et al. Blepharitis Preferred Practice Pattern\u00ae. Ophthalmology. 2019;126(1):56\u201393.","journal-title":"Ophthalmology"},{"issue":"1","key":"205_CR7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ophtha.2018.10.020","volume":"126","author":"DM Varu","year":"2019","unstructured":"Varu DM, Rhee MK, Akpek EK, et al. Conjunctivitis Preferred Practice Pattern\u00ae. Ophthalmology. 2019;126(1):94\u2013169.","journal-title":"Ophthalmology"},{"issue":"2 Suppl","key":"205_CR8","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S1542-0124(12)70620-1","volume":"7","author":"MA Lemp","year":"2009","unstructured":"Lemp MA, Nichols KK. Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. Ocul Surf. 2009;7(2 Suppl):S1\u201314.","journal-title":"Ocul Surf."},{"issue":"5","key":"205_CR9","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1089\/jop.2009.0026","volume":"25","author":"EK Akpek","year":"2009","unstructured":"Akpek EK, Vittitow J, Verhoeven RS, et al. Ocular surface distribution and pharmacokinetics of a novel ophthalmic 1% azithromycin formulation. J Ocul Pharmacol Ther. 2009;25(5):433\u201340.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"5","key":"205_CR10","doi-asserted-by":"publisher","first-page":"744-751.e2","DOI":"10.1016\/j.ajo.2010.05.039","volume":"150","author":"WC Stewart","year":"2010","unstructured":"Stewart WC, Crean CS, Zink RC, Brubaker K, Haque RM, Hwang DG. Pharmacokinetics of azithromycin and moxifloxacin in human conjunctiva and aqueous humor during and after the approved dosing regimens. Am J Ophthalmol. 2010;150(5):744-751.e2.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"205_CR11","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1128\/AAC.49.6.2372-2377.2005","volume":"49","author":"M Bosnar","year":"2005","unstructured":"Bosnar M, Kelneri\u0107 \u017d, Muni\u0107 V, Erakovi\u0107 V, Parnham MJ. Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin. Antimicrob Agents Chemother. 2005;49(6):2372\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"205_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1128\/AAC.29.1.163","volume":"29","author":"I Hayakawa","year":"1986","unstructured":"Hayakawa I, Atarashi S, Yokohama S, Imamura M, Sakano K, Furukawa M. Synthesis and antibacterial activities of optically active ofloxacin. Antimicrob Agents Chemother. 1986;29(1):163\u20134.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"205_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1128\/AAC.31.2.325","volume":"31","author":"M Imamura","year":"1987","unstructured":"Imamura M, Shibamura S, Hayakawa I, Osada Y. Inhibition of DNA gyrase by optically active ofloxacin. Antimicrob Agents Chemother. 1987;31(2):325\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"205_CR14","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1128\/AAC.32.9.1336","volume":"32","author":"T Une","year":"1988","unstructured":"Une T, Fujimoto T, Sato K, Osada Y. In vitro activity of DR-3355, an optically active ofloxacin. Antimicrob Agents Chemother. 1988;32(9):1336\u201340.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"205_CR15","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1185\/03007990802480091","volume":"24","author":"M Fukuda","year":"2008","unstructured":"Fukuda M, Sasaki H. Calculation of AQCmax: comparison of five ophthalmic fluoroquinolone solutions. Curr Med Res Opin. 2008;24(12):3479\u201386.","journal-title":"Curr Med Res Opin"},{"issue":"7","key":"205_CR16","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1124\/dmd.117.075473","volume":"45","author":"N Asano","year":"2017","unstructured":"Asano N, Ueda K, Kawazu K. Penetration Route of the selective glucocorticoid receptor agonist sa22465 and betamethasone into rabbit meibomian gland based on pharmacokinetics and autoradiography. Drug Metab Dispos. 2017;45(7):826\u201333.","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"205_CR17","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s40123-018-0141-y","volume":"7","author":"PA Asbell","year":"2018","unstructured":"Asbell PA, Pandit RT, Sanfilippo CM. Antibiotic resistance rates by geographic region among ocular pathogens collected during the armor surveillance study. Ophthalmol Ther. 2018;7(2):417\u201329.","journal-title":"Ophthalmol Ther."},{"key":"205_CR18","first-page":"1369","volume":"5","author":"W Haas","year":"2011","unstructured":"Haas W, Gearinger LS, Usner DW, DeCory HH, Morris TW. Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: etiology of bacterial conjunctivitis and antibacterial susceptibility profile. Clin Ophthalmol. 2011;5:1369\u201379.","journal-title":"Clin Ophthalmol."},{"issue":"3","key":"205_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1128\/AAC.33.3.277","volume":"33","author":"RP Gladue","year":"1989","unstructured":"Gladue RP, Bright GM, Isaacson RE, Newborg MF. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob Agents Chemother. 1989;33(3):277\u201382.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"205_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1179\/joc.1997.9.1.23","volume":"9","author":"A Fietta","year":"1997","unstructured":"Fietta A, Merlini C, Grassi GG. Requirements for intracellular accumulation and release of clarithromycin and azithromycin by human phagocytes. J Chemother. 1997;9(1):23\u201331.","journal-title":"J Chemother"},{"issue":"suppl A","key":"205_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/jac\/25.suppl_A.73","volume":"25","author":"G Foulds","year":"1990","unstructured":"Foulds G, Shepard RM, Johnson RB. The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother. 1990;25(suppl A):73\u201382.","journal-title":"J Antimicrob Chemother"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-019-00205-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-019-00205-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-019-00205-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T14:02:41Z","timestamp":1713362561000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-019-00205-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,1]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["205"],"URL":"https:\/\/doi.org\/10.1007\/s40123-019-00205-0","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"type":"print","value":"2193-8245"},{"type":"electronic","value":"2193-6528"}],"subject":[],"published":{"date-parts":[[2019,8,1]]},"assertion":[{"value":"28 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}